World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
38241
World Ranking
9572
National Ranking
525

Ralf Gold publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ralf Gold sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 784 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ralf Gold D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ralf Gold sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ralf Gold is affiliated with Ruhr University Bochum in Germany and has made substantial contributions to the field of medicine, focusing prominently on neurology and immunology. Their research agenda encompasses multiple sclerosis and related neurological disorders, with a broad engagement in pathology, forensic medicine, oncology, and molecular biology.

The main topics of their work include:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Hereditary Neurological Disorders
  • Polyomavirus and related diseases
  • Peripheral Nerve Disorders
  • Parkinson's Disease Mechanisms and Treatments
  • Myasthenia Gravis and Thymoma

They have published extensively in key journals, with frequent publication venues consisting of:

  • Neurology
  • Therapeutic Advances in Neurological Disorders
  • Journal of Neurology
  • Neurology Neuroimmunology & Neuroinflammation
  • Multiple Sclerosis Journal

Ralf Gold's recent publications highlight their focus on immunomodulation and neurological disease management. Notable papers include:

  • "Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism," 2020, Cell
  • "Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism," 2021, European Heart Journal
  • "Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)," 2021, Therapeutic Advances in Neurological Disorders
  • "Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management," 2023, Journal of Neurology
  • "Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders," 2021, Neurology Neuroimmunology & Neuroinflammation

The researcher has collaborated frequently with a group of co-authors including Jeremias Motte, Kalliopi Pitarokoili, Anna Lena Fisse, Simon Faissner, and Thomas Grüter.

Best Publications

  • Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

    Ralf Gold;Ludwig Kappos;Douglas L Arnold;Amit Bar-Or

  • Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution.

    Takahiro Masuda;Roman Sankowski;Ori Staszewski;Chotima Böttcher

  • Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway

    Ralf A Linker;De-Hyung Lee;Sarah Ryan;Anne M van Dam

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine

    Aiden Haghikia;Stefanie Jörg;Alexander Duscha;Johannes Berg

  • Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

    Ludwig Kappos;Ralf Gold;David H Miller;David G MacManus

  • Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism

    Alexander Duscha;Barbara Gisevius;Sarah Hirschberg;Nissan Yissachar

  • Sex and gender issues in multiple sclerosis

    Hanne F. Harbo;Ralf Gold;Mar Tintoré

  • TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

    Adam P. Gregory;Calliope A. Dendrou;Kathrine E. Attfield;Aiden Haghikia;Aiden Haghikia

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • Tumor Recurrence and Survival in Patients Treated for Thymomas and Thymic Squamous Cell Carcinomas: A Retrospective Analysis

    Philipp Ströbel;Andrea Bauer;Bernhard Puppe;Til Kraushaar

  • Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis

    Rajneesh Srivastava;Muhammad Aslam;Sudhakar Reddy Kalluri;Lucas Schirmer

  • Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

    G Giancarlo Comi;A. Pulizzi;Marco Rovaris;O. Abramsky

  • Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system

    Alexander Baraniskin;Jan Kuhnhenn;Uwe Schlegel;Andrew Chan

  • Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

    Simon Faissner;Simon Faissner;Jason R Plemel;Ralf Gold;V Wee Yong

  • Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

    Ralf Gold;Gavin Giovannoni;Krzysztof Selmaj;Eva Havrdova

  • Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

    Nico Melzer;Tobias Ruck;Peter Fuhr;Ralf Gold

  • Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab.

    Per Soelberg Sørensen;Antonio Bertolotto;Gilles Edan;Gavin Giovannoni

  • Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder.

    Marius Ringelstein;Ilya Ayzenberg;Jens Harmel;Ann-Sophie Lauenstein

  • Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy

    Ilya Ayzenberg;Ingo Kleiter;Alexandra Schröder;Kerstin Hellwig

Frequent Co-Authors

Andrew T. Chan
Andrew T. Chan Harvard University
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Heinz Wiendl
Heinz Wiendl University of Münster
Frauke Zipp
Frauke Zipp Johannes Gutenberg University of Mainz
Amit Bar-Or
Amit Bar-Or University of Pennsylvania
Eva Havrdova
Eva Havrdova Charles University
Hans-Peter Hartung
Hans-Peter Hartung Heinrich Heine University Düsseldorf
Krzysztof Selmaj
Krzysztof Selmaj University of Warmia and Mazury in Olsztyn
Friedemann Paul
Friedemann Paul Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare degrees and career pathways can open doors to diverse roles in medicine, patient care, and public health. For those looking to bypass lengthy prerequisites, consider nursing schools that don't require teas, offering a streamlined entry to nursing careers without standardized test hurdles.

Leadership roles in healthcare are in high demand. Completing one of the top healthcare administration programs can prepare you for management positions in hospitals, clinics, or health organizations—all through fast-track online options.

If you’re already an RN aiming to advance, adn to fnp bridge programs provide a flexible route to become a Family Nurse Practitioner, expanding your scope of practice and responsibility.

For those interested in preventive care and wellness, an accredited nutrition degrees online can prepare you for rewarding roles in dietary planning, research, or public health education. These pathways support a future in medicine or related healthcare fields with flexible, accredited online study.

Best Scientists Citing Ralf Gold

Trending Scientists

Recently Published Articles